UPDATE: Morgan Stanley Raises PT to $55 on Verisk Analytics on Solid Q4, Healthcare Strength
Morgan Stanley maintained Verisk Analytics (NASDAQ: VRSK) with an Equal-weight rating and raised the price target from $47.00 to $55.00.
Morgan Stanley noted, "We view VRSK as one of the more stable, defensive analytics companies in our coverage. The company is the dominant provider of data and analytics to the Property Casualty Insurance industry, also servicing the mortgage, healthcare, and supply chain verticals. P&C trends are improving and we expect Healthcare to remain a key growth driver. … While we think Verisk has one of the best business models in our broader business services universe, this is reflected in the stock price."
Verisk Analytics closed at $53.90 on Tuesday.
Latest Ratings for VRSK
|May 2014||Deutsche Bank||Maintains||Buy|
|Apr 2014||Keefe Bruyette & Woods||Suspends||Market Perform|
|Feb 2014||Morgan Stanley||Maintains||Overweight|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.